drugset / Trial / NCT02040844
Phase III Cat-PAD Follow-on Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the continued effectiveness and safety of Cat-PAD in cat allergic subjects for up to five years after the start of administration of treatment. The study is an optional follow-up study to a phase III double-blind, placebo controlled, Cat-PAD study; no further investigational product is administered.
Timeline
- Start
- 2014-02
- Primary completion
- 2017-05
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cat-PAD | Peptide | — | — |
Indications
No indication recorded.